Cite
HARVARD Citation
Invernizzi, F. et al. (n.d.). Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: Safety and survival. Digestive and liver disease. 50 (1), pp. 49-. [Online].